The publisher's Medical Devices sector report, “Coronary Artery Bypass Graft Surgery Devices - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Coronary Artery Bypass Graft Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Coronary Artery Bypass Graft Surgery Devices are used in the surgery to improve blood flow to the obstructed coronary artery. Surgeons use these devices to treat people who have severe coronary heart disease.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Coronary Artery Bypass Graft Surgery Devices are used in the surgery to improve blood flow to the obstructed coronary artery. Surgeons use these devices to treat people who have severe coronary heart disease.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Coronary Artery Bypass Graft Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Coronary Artery Bypass Graft Surgery Devices - Pipeline Products under Development by Companies
5 Coronary Artery Bypass Graft Surgery Companies and Product Overview
6 Coronary Artery Bypass Graft Surgery- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AdvanSource Biomaterials Corporation
- ArtiFex Medical GmbH
- Axcelon Biopolymers Corp
- CardioPolymers Inc
- Cardious Inc
- Centre Hospitalier Universitaire de Nice
- Coromedic Ltd.
- Cytograft Tissue Engineering Inc (Inactive)
- Elana bv
- enVVeno Medical Corp
- Graft-Loc Inc.
- H. Lee Moffitt Cancer Center & Research Institute Inc
- iiTech BV
- McGill University
- Medical 21 Inc
- Myocardial Assist Systems and Technology LLC
- Neograft Technologies Inc
- PetVivo Holdings Inc
- Prekubator TTO
- RegenMedTX LLC
- Rox Medical Inc
- SeamVad Ltd.
- Surg Solutions SL
- Synovis Micro Companies Alliance Inc
- Thoratec LLC
- Tissue Regeneration Technologies LLC
- University College London
- University of Arizona
- University of California Los Angeles
- Xeltis AG
